New Zealand markets closed

RPRX Dec 2022 50.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.40000.0000 (0.00%)
As of 03:58PM EDT. Market open.
Full screen
Previous close1.4000
Open1.3000
Bid0.6000
Ask1.2500
Strike50.00
Expiry date2022-12-16
Day's range1.0800 - 1.4000
Contract rangeN/A
Volume15
Open interest1.52k
  • GlobeNewswire

    Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders

    New capital deployment target of $10-12 billion over the next five yearsOutlook for 2020-2025 Adjusted Cash Receipts (1) (non-GAAP) CAGR raised to 11-14%Adjusted Cash Receipts (1) (non-GAAP) expected to grow 10% or more over this decade, positioning Royalty Pharma to be one of the fastest growing biopharma companiesDemand for capital to fund life sciences innovation to exceed $1 trillion in next decade NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) will host its ina

  • GlobeNewswire

    Royalty Pharma Reports First Quarter 2022 Results

    Net cash provided by operating activities (GAAP) of $460 million; Adjusted Cash Receipts(1) (non-GAAP) of $605 million Announced transactions of up to $450 million in Q1 20222022 guidance reaffirmed: Adjusted Cash Receipts(1) expected to be $2,225 to $2,300 million NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2022 and reaffirmed full-year 2022 guidance for Adjusted Cash Receipts(1) (a non-GAAP financial mea

  • Simply Wall St.

    With Royalty Pharma plc (NASDAQ:RPRX) It Looks Like You'll Get What You Pay For

    Royalty Pharma plc's ( NASDAQ:RPRX ) price-to-earnings (or "P/E") ratio of 41.8x might make it look like a strong sell...